(Q35195407)

7 August 2017

1 reference

title

American Society of Gene Therapy (ASGT) ad hoc subcommittee on retroviral-mediated gene transfer to hematopoietic stem cells (English)

1 reference

7 August 2017

0 references

1

1 reference

7 August 2017

Cynthia Dunbar

3

0 references

Jan Nolta

object named as

Jan Nolta

12

0 references

Harry Malech

object named as

Harry Malech

13

0 references

Hans-Peter Kiem

5

object named as

Hans-Peter Kiem

1 reference

7 August 2017

11

Brian Sorrentino

1 reference

7 August 2017

16

Joy Cavagnaro

1 reference

7 August 2017

9

C Anthony Blau

1 reference

7 August 2017

14

Malcolm Brenner

1 reference

7 August 2017

Michel Sadelain

2

1 reference

7 August 2017

David Bodine

4

1 reference

7 August 2017

Fabio Candotti

6

1 reference

7 August 2017

John Tisdale

7

1 reference

7 August 2017

Isabelle Riviére

8

1 reference

7 August 2017

Robert E Richard

10

1 reference

7 August 2017

Kenneth Cornetta

15

1 reference

7 August 2017

Katherine High

17

1 reference

7 August 2017

Joseph Glorioso

18

1 reference

7 August 2017

American Society of Gene Therapy (ASGT)

19

1 reference

7 August 2017

1 August 2003

1 reference

7 August 2017

1 reference

7 August 2017

8

1 reference

7 August 2017

180-187

1 reference

7 August 2017

2

1 reference

Gene transfer into humans--immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction

7 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900212-0

7 January 2021

Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900212-0

7 January 2021

Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900212-0

7 January 2021

Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900212-0

7 January 2021

A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900212-0

7 January 2021

Expression of human adenosine deaminase in murine hematopoietic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900212-0

7 January 2021

Murine leukemia induced by retroviral gene marking

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900212-0

7 January 2021

Sturm und drang over suicidal lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900212-0

7 January 2021

Retroviral transduction of enriched hematopoietic stem cells allows lifelong Bcl-2 expression in multiple lineages but does not perturb hematopoiesis

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900212-0

7 January 2021

Persisting multilineage transgene expression in the clonal progeny of a hematopoietic stem cell

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900212-0

7 January 2021

Drug selection of MDR1-transduced hematopoietic cells ex vivo increases transgene expression and chemoresistance in reconstituted bone marrow in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900212-0

7 January 2021

Efficient retrovirus-mediated transfer of the multidrug resistance 1 gene into autologous human long-term repopulating hematopoietic stem cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900212-0

7 January 2021

10.1016/S1525-0016(03)00212-0

Identifiers

DOI

1 reference

7 August 2017

1 reference